This study used transcriptomics, immune profiling, and metabolomics on esophageal biopsies and blood from 17 children with EoE and 15 controls to characterize local and systemic signatures.
Frontiers in Immunology · 15 authors, 8 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This study used transcriptomics, immune profiling, and metabolomics on esophageal biopsies and blood from 17 children with EoE and 15 controls to characterize local and systemic signatures.
The study conducted untargeted transcriptomics on esophageal biopsies, comprehensive immune analysis of biopsies and blood via flow cytometry, and non-targeted plasma metabolomics in children with EoE (n=17) versus controls (n=15). Transcriptomics revealed conserved immune dysregulation involving innate and adaptive pathways, epithelial barrier dysfunction, and perception of chemical stimuli. Immune analysis showed complex local inflammation with dysregulation of T1, T2, and T3 immunity. Systemically, an immune signature in blood was found, but non-targeted metabolomics more efficiently discriminated EoE, showing dysregulation of vitamin B6 and amino acid metabolism. Multi-omics integration suggested a plasma signature combining metabolomics and cytokines could serve as a diagnostic biomarker. Limitations include the small sample size and the need for validation in larger, independent cohorts. The findings support EoE as a complex disorder beyond T2 dysregulation and provide proof-of-concept for potential plasma biomarkers.